This Article Full Text Full Text (PDF) Online Supplement All Versions of this Article: 200710-1513OCv1 178/1/50    most recent Alert me when this article is cited Alert me if a correction is posted Services Related articles in AJRCCM Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Google Scholar Articles by Stathopoulos, G. T. Articles by Kalomenidis, I. PubMed PubMed Citation Articles by Stathopoulos, G. T. Articles by Kalomenidis, I.

Zoledronic Acid Is Effective against Experimental Malignant Pleural Effusion

¹ Applied Biomedical Research and Training Center "Marianthi Simou" and "George P. Livanos" Laboratory, Department of Critical Care and Pulmonary Services, General Hospital "Evangelismos," School of Medicine, National and Kapodistrian University of Athens, Athens, Greece; and ² Second Pulmonary Department, "Attikon" University Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

Correspondence and requests for reprints should be addressed to Georgios T. Stathopoulos, M.D., Ph.D., 3 Ploutarhou Str., 10675 Athens, Greece. E-mail: gstathop{at}med.uoa.gr

Rationale: Aminobiphosphonates, such as zoledronic acid (ZA), exert potent indirect antitumor effects and are currently being tested against human solid tumors. The antitumor actions of aminobiphosphonates, including angiostasis, are relevant to the pathogenesis of malignant pleural effusion (MPE), but no study has addressed the efficacy of these compounds against malignant pleural disease.

Objectives: Here we hypothesized that treatment of immunocompetent mice with ZA would halt tumor progression in a mouse model of adenocarcinoma-induced MPE.

Methods: To induce MPE in mice, Lewis lung carcinoma cells were delivered directly into the pleural space. Subsequently, animals were treated with ZA in both a prevention and a regression protocol.

Measurements and Main Results: ZA treatment resulted in significant reductions in pleural fluid accumulation and tumor dissemination, while it significantly prolonged survival. These effects of ZA were linked to enhanced apoptosis of pleural tumor cells, decreased formation of new vessels in pleural tumors, and reduced pleural vascular permeability. In addition, ZA was able to inhibit the recruitment of mononuclear cells to pleural tumors, with concomitant reductions in matrix metalloproteinase-9 release into the pleural space. Finally, ZA limited the expression of proinflammatory and angiogenic mediators, as well as the activity of small GTP proteins Ras and RhoA, in tumor cells in vivo and in vitro.

Conclusions: ZA is effective against experimental MPE, suggesting that this intervention should be considered for testing in clinical trials.

Key Words: pleural disease • monocyte chemoattractant protein • vascular endothelial growth factor • angiogenesis • aminobiphosphonate

AT A GLANCE COMMENTARY Scientific Knowledge on the Subject No specific treatment is available for malignant pleural effusion. What This Study Adds to the Field In this experimental study in mice, the aminobiphosphonate zoledronic acid was effective against malignant pleural effusion.

 

Related articles in AJRCCM:

Malignant Pleural Effusions: Fixing the Leaky Faucet

Y. C. Gary Lee and Sylwia Wilkosz
AJRCCM 2008 178: 3-5. [Full Text]  

This article has been cited by other articles:

				G. T. Stathopoulos, I. Psallidas, A. Moustaki, C. Moschos, A. Kollintza, S. Karabela, I. Porfyridis, S. Vassiliou, M. Karatza, Z. Zhou, et al. A Central Role for Tumor-derived Monocyte Chemoattractant Protein-1 in Malignant Pleural Effusion J Natl Cancer Inst, October 15, 2008; 100(20): 1464 - 1476. [Abstract] [Full Text] [PDF]

				Y. C. G. Lee and S. Wilkosz Malignant Pleural Effusions: Fixing the Leaky Faucet Am. J. Respir. Crit. Care Med., July 1, 2008; 178(1): 3 - 5. [Full Text] [PDF]